期刊文献+

异烟腙类衍生物TJU103体外对人T淋巴细胞活化功能的影响

Effects of TJU103 on T Lymphoytes activation in vitro
下载PDF
导出
摘要 目的 探讨异烟腙类衍生物 TJU10 3体外对人 T淋巴细胞活化功能的影响。方法 体外建立 HL A半相合供、受者间单向混合淋巴细胞培养 (ML C)体系 ,应用 TJU10 3阻断 CD4 T细胞激活的抗原信号通路 ,利用MTT法检测 T淋巴细胞的增殖和细胞毒活性 ,酶联免疫吸附法 (EL ISA)检测对 T淋巴细胞分泌细胞因子的影响。结果  TJU10 3能明显降低 HL A半相合供、受者间混合淋巴细胞增殖反应 ,以及肿瘤坏死因子 α(TNF- α)和 γ干扰素 (IFN-γ)等炎性细胞因子的分泌 (P <0 .0 1) ,但不影响供者 T细胞对原代白血病细胞的杀伤效应 (P >0 .0 5 )。结论  TJU10 3能特异性地与 CD4 T淋巴细胞结合 ,阻断 CD4 T淋巴细胞激活的抗原信号通路 ,在明显降低 T淋巴细胞增殖反应和炎性细胞因子分泌的同时 ,不影响其细胞毒作用发挥 。 Objective To investigate the effects of TJU103 on T lymphocytes activation in vitro.Methods MTT and ELISA assays were used respectively to detect the proliferation,cytotoxicity and the cytokine production of donor T lymphocytes blocked by TJU103.Results There was no differences in the ability of anti-leukemia between each group,but there was significant difference in the prohibition of T-cell proliferation and the cytokine production between groups of TJU103.Conclusion TJU103 may prohibit the T-cell proliferation and the cytokine production significantly but the ability of anti-leukemia is not influenced.
出处 《山东医药》 CAS 北大核心 2004年第4期19-21,共3页 Shandong Medical Journal
基金 全军医学科学技术研究"十五"计划重点课题 ( No.0 1Z0 2 5 0 )
关键词 异烟腙类衍生物 TJU1O3 体外 人T淋巴细胞活化 重度移植物抗宿主病 白血病 TJU103 T lymphocytes Proliferation Cytotoxicity Cytokine
  • 相关文献

参考文献9

  • 1Carmichael J,Gnaff WG.Gadzer AF.et al.Evaluation a tetrazolium based semi—automated colorimetric assessment ofchemosensitive tesring.Cancer Res,1987,47:936~942.
  • 2Fishman JA.Rubin RH.Infection inorgan—transplant recipients.N Engl J Med,1998,338:1741~1751.
  • 3Aversa F.Tabilio A,Velardi A.et al.Treatment of high risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.N EnglJ Med.1998,339:1186~11 93.
  • 4Korngold R. Sprent J.T cell subsets and graft—versus—hostdisease.Transplantation.1987,44:335~339.
  • 5Ferrara JLM,Deeg HJ.G raft—versus—hostdisease.N Engl J Med.1991,324:667~674.
  • 6Li S. Gao JM. Satoh TS.et al.A computer screening approach to immunoglobulin superfamily structures and interactions:discovery of small non—peptidic CD4 inhibitors as novel immunotherapeutics.Proc Natl Acad Sci USA,1997,94:73~78.
  • 7Edling AE.Choksi S,Huang Z.et al.An organic CD4 inhibitor reduces the clinical and pathological symptoms of acute experimental allergic encephalomyelitis.J Autoimmun.2002,1 8 (2):169~1 79.
  • 8Krakauer T.Coordinate suppression of superantigen—induced cytokine production and T—cell proliferation by a small nonpeptidic inhibitor of class I major histocompatibility complex and CD4 interaction.Antimicrobial Agents and Chemotherapy.2000,44:1067~1069.
  • 9Zeis M,Uharek L,Hartung G.et al.Graft—vs—leukemia activity and graft—vs—host disease induced by allogeneic Th1—and Th2-type CD^+4 cells in mice.Hematol J.2001,2(2):136~144.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部